Suppression of IL-10 production by calcitriol in patients with multiple sclerosis

被引：14

作者：

Niino, Masaaki ^{[1
]}

Fukazawa, Toshiyuki ^{[2
]}

Miyazaki, Yusei ^{[1
,3
]}

Takahashi, Eri ^{[1
]}

Minami, Naoya ^{[3
]}

Amino, Itaru ^{[3
]}

Fujiki, Naoto ^{[3
]}

Doi, Shizuki ^{[3
]}

Kikuchi, Seiji ^{[3
]}

机构：

[1] Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido 0630005, Japan

[2] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan

[3] Hokkaido Med Ctr, Dept Neurol, Sapporo, Hokkaido 0630005, Japan

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 270卷 / 1-2期

关键词：

Vitamin D; Multiple sclerosis; Cytokine; IL-10; Disability; CD4(+) T-CELLS; 1,25-DIHYDROXYVITAMIN D-3; VITAMIN-D; DENDRITIC CELLS; DOWN-REGULATION; DIFFERENTIATION; EXPRESSION; MONOCYTES; SYSTEM; TRIAL;

D O I：

10.1016/j.jneuroim.2014.03.011

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated whether calcitriol (1,25-dihydroxyvitamin D) differentially modulates cytokine production by peripheral blood mononuclear cells from multiple sclerosis (MS) patients compared with that from healthy controls. In response to phytohemagglutinin (PHA) or lipopolysaccharide (LPS), cytokine level in a calcitriol-added sample was normalized to that in a calcitriol-absent sample, and this relative unit was compared. The relative unit of IL-12/23(p40) in LPS-stimulation was higher in MS patients. Moreover, the relative unit of IL-10 in PHA-stimulation was lower in MS patients, and negatively correlated with the Expanded Disability Status Scale. The anti-inflammatory response to vitamin D may be reduced in MS. (C) 2014 Elsevier B.V. All rights reserved.

引用

页码：86 / 94

页数：9

共 50 条

[21] IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis
Wergeland, S
Beiske, A
Nyland, H
Hovdal, H
Jensen, D
Larsen, JP
Maroy, TH
Smievoll, AI
Vedeler, CA
Myhr, KM
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (03) : 171 - 175
[22] IL-12 INHIBITS THE PRODUCTION OF IL-10 IN PATIENTS WITH SJOGREN SYNDROME
Yao, G.
Chen, W.
Tang, X.
Feng, X.
Sun, L.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 950 - 950
[23] Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
Blumenfeld, Shiri
Staun-Ram, Elsebeth
Miller, Ariel
JOURNAL OF AUTOIMMUNITY, 2016, 70 : 40 - 51
[24] IL-10 or not IL-10: that is the question
Dragana Jankovic
Giorgio Trinchieri
Nature Immunology, 2007, 8 : 1281 - 1283
[25] IL-10 or not IL-10: that is the question
Jankovic, Dragana
Trinchieri, Giorgio
NATURE IMMUNOLOGY, 2007, 8 (12) : 1281 - 1283
[26] Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10
Ireland, Sara J.
Monson, Nancy L.
Davis, Laurie S.
CYTOKINE, 2015, 73 (02) : 236 - 244
[27] Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites
MacDonald, AS
Maizels, RM
Lawrence, RA
Dransfield, I
Allen, JE
JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1304 - 1312
[28] Correlations Between Peripheral Blood Mononuclear Cell Production of BDNF TNF-alpha, IL-6, IL-10 and Cognitive Performances in Multiple Sclerosis Patients
Patanella, A. K.
Zinno, M.
Quaranta, D.
Nociti, V.
Frisullo, G.
Gainotti, G.
Tonali, P. A.
Batocchi, A. P.
Marra, C.
JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (05) : 1106 - 1112
[29] First clinical experience of autogenic IL-10 modified dendritic cells in multiple sclerosis
Odinak, M.
Bisaga, G.
Chirsky, V.
Baldueva, I.
Moiseyenko, V.
Neckhaeva, T.
Kalinina, N.
Davidova, N.
Paschenkov, M.
Ciumas, C.
MULTIPLE SCLEROSIS, 2009, 15 (09): : S143 - S143
[30] IL-10 in Humans: Lessons from the Gut, IL-10/IL-10 Receptor Deficiencies, and IL-10 Polymorphisms
Engelhardt, Karin R.
Grimbacher, Bodo
INTERLEUKIN-10 IN HEALTH AND DISEASE, 2014, 380 : 1 - 18

← 1 2 3 4 5 →